logo
A heart of gold: Atrium Health brings life-saving surgery to Barbados

A heart of gold: Atrium Health brings life-saving surgery to Barbados

For years, Karen Haynes, a 52-year-old guidance counselor from Barbados, struggled with the debilitating effects of hypertrophic cardiomyopathy (HCM), a genetic condition that affects the main pumping chamber of the heart. Once an active individual who enjoyed beach strolls and workplace fitness activities, Haynes found herself unable to perform even the simplest tasks, like climbing stairs or responding quickly to student emergencies.
Haynes, a dedicated mother and wife to her husband of more than 20 years, soon found herself struggling to do the things she always loved.
'One of my favorite self-care activities is walking on the soft, white sandy shores of the beaches of my beautiful island paradise,' Haynes recalls.
HCM affects the walls of the left ventricle, and they can become thick and stiff. Over time, the heart can't take in or pump out enough blood during each heartbeat to supply the body's needs.
The shortness of breath and fatigue became unbearable, and after extensive research, Haynes knew she needed expert care. As her condition worsened, she researched about her condition, joined webinars and online meetings, learning more about the potentially life-saving surgical options that patients like her could benefit from.
Her relatives, currently residing in the U.S., pointed her to the nearby facility at Atrium Health Sanger Heart & Vascular Institute. After a virtual consultation with Dr. Dermot Phelan, he confirmed the severity of her condition. In March 2023, Haynes traveled to Atrium Health in Charlotte, where advanced testing revealed her high risk of sudden cardiac death. Although she received a defibrillator upon her return to Barbados, Haynes' condition continued to decline, and it became evident that surgery was her only option.
expand
A unique solution: Bringing expertise to Barbados
The thought of undergoing such a complex procedure was daunting, particularly since there were no surgeons in Barbados experienced in performing septal myectomies, a procedure that involves the surgical removal of a portion of the thickened heart muscle (septum) to improve blood flow and relieve obstruction in patients with hypertrophic cardiomyopathy (HCM).
Additionally, the financial burden of traveling back to the U.S. for surgery seemed insurmountable — Haynes' insurance had classified her condition as pre-existing, and the costs would not be covered. Then, what Haynes describes as a 'miracle' happened.
In what felt like divine intervention to Haynes, Atrium Health, through its International Medical Outreach Program, made the extraordinary decision to bring the expertise to her. Dr. Larry Watts, a world-renowned cardiothoracic surgeon, led the effort, traveling with his surgical team — including perfusionist Mindy Couper and scrub technician Kayla Boutross — to Queen Elizabeth Hospital in Barbados. The team collaborated with local cardiothoracic surgeon Dr. Alan Smith, anesthesiologist Dr. Michael Fakoory and interventional cardiologist Dr. Dawn Scantlebury to successfully perform the surgery, a first for the country.
'It was like going into someone else's home, cooking in their kitchen and sleeping in their bed — you have to be respectful,' says Watts. 'But the team in Barbados was incredibly gracious and eager to learn.'
'This was a direct answer to prayer and the exhilarating reassurance that miracles happen still,' Haynes says. 'I knew this surgery would give me my life back, and I am forever grateful.'
Using FaceTime, Phelan provided real-time assistance from Charlotte, guiding the team through crucial moments of the procedure and ensuring the best possible outcome.
'This wasn't just about saving one life — it was about proving what's possible,' says Watts. 'Now there's a pathway for more patients in Barbados to receive this kind of care.'
A successful outcome
The surgery was a success, and Haynes' life was transformed. Gone were the relentless struggles to breathe, the crippling fatigue and the fear that had forced her to give up cherished beach strolls with her husband after a frightening fall near the water's edge — an episode she later realized was caused by her condition.
'Regardless of a person's strength of character or pain tolerance, there are certain things that are utterly incapacitating — and the inability to breathe is one of them,' Haynes says. 'I now have the opportunity to live again, to enjoy the simple joys of life I had to give up.'
Her recovery was met with joy and gratitude, not just from her family, but from an entire medical community that had come together to make history. Watts and his team's dedication had not only given Haynes a second chance, but also paved the way for improved cardiac care in Barbados.
expand
The Hypertrophic Cardiomyopathy Center of Excellence
Haynes' story is a shining example of the expertise housed at Atrium Health Sanger Heart & Vascular Institute's Hypertrophic Cardiomyopathy Center of Excellence. Recognized as one of only 46 such centers in the United States and one of two in North Carolina, the center offers comprehensive diagnostics, advanced therapies and access to clinical trials for patients like Haynes.
'Over the past five years, we've expanded from one HCM clinic every two weeks to two clinics weekly, with a multidisciplinary team of four cardiologists and two advanced practice providers,' Phelan says. 'We've also participated in multiple landmark clinical trials and strive to bring new therapeutic options to our patients.'
The center's dedication to innovation and excellence makes it a beacon for patients worldwide, particularly those in regions where specialized care is unavailable.
"Our Hypertrophic Cardiomyopathy Center of Excellence in Charlotte offers comprehensive, state-of-the-art care, combining advanced imaging, cutting-edge treatments and access to groundbreaking clinical trials," says Phelan. "With a dedicated team of specialists, we provide individualized care plans, ensuring patients receive the most precise and effective therapies available for managing HCM."
The broader impact
Haynes' journey is not just about one patient's recovery —it's about what is possible when medical institutions prioritize global health and outreach. Her experience serves as a call to action for increased collaboration between institutions like Atrium Health and hospitals in underserved regions. She now dreams of a future where Barbados has its own Center of Excellence for hypertrophic cardiomyopathy, allowing more patients in the Caribbean to receive lifesaving care.
'There are likely many more patients in Barbados and the wider Caribbean who need this surgery,' Haynes says. 'I hope my experience serves as a catalyst for building a sustainable program where they, too, can receive treatment without the same challenges I faced.'
Her gratitude extends beyond the surgical team to her family, friends and local colleagues who supported her through the toughest times. She remains especially thankful for the unwavering dedication of the Atrium Health team, from Watts and Phelan to the compassionate staff who went beyond their call of duty to offer reassurance and support.
Looking ahead
For Atrium Health, Haynes' case is a stepping stone toward even greater international collaboration. The team hopes to build upon this success, refining their outreach efforts and exploring ways to enhance partnerships with hospitals worldwide.
'This case shows what's possible when we combine expertise, technology and compassion,' Watts says. 'It's about creating a legacy of care that extends beyond borders.'
Haynes, now feeling healthier and stronger, looks forward to resuming the activities she once cherished — teaching her students without limitation, walking along the beach with her husband and simply enjoying the gift of breath.
Atrium Health's work in Barbados serves as a powerful reminder that health care innovation knows no borders. Through dedication, expertise and collaboration, lives are being changed — one patient, one surgery, one miracle at a time.
Atrium Health is a nationally recognized leader in shaping health outcomes through innovative research, education and compassionate patient care. Based in Charlotte, North Carolina, Atrium Health is an integrated, nonprofit health system with more than 70,000 teammates serving patients at 40 hospitals and more than 1,400 care locations.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Richard Guiltinan Joins Vartabedian Hester & Haynes
Richard Guiltinan Joins Vartabedian Hester & Haynes

Business Wire

time05-08-2025

  • Business Wire

Richard Guiltinan Joins Vartabedian Hester & Haynes

DALLAS--(BUSINESS WIRE)--Richard J. Guiltinan has joined the Dallas office of Vartabedian Hester & Haynes LLP as the latest addition to the law firm's white collar and investigations practice group. Mr. Guiltinan joins the firm from the U.S. Attorney's Office for the Northern District of Texas, where he has served since 2017 as a civil prosecutor for False Claims Act and healthcare fraud investigations. Mr. Guiltinan joins the firm from the U.S. Attorney's Office for the Northern District of Texas, where he has served since 2017 as a civil prosecutor for False Claims Act and healthcare fraud investigations. He was lead attorney in multiple complex matters, including successful lawsuits against a pharmacy management company and its executives, a pain management clinic, and a clinical laboratory. His practice also focused on investigations related to tariffs and trade obligations. In addition, he served for three years as the Civil Healthcare Fraud Coordinator for the Northern District of Texas. Prior to joining the DOJ, Mr. Guiltinan was an associate in the Dallas office of Haynes and Boone for six years. While in private practice, he represented multiple clients in governmental investigations involving fraud, antitrust claims and securities litigation. 'Richard is bringing the perspectives gained while prosecuting white collar cases, coupled with his years in private practice,' says Conrad Hester, the firm's managing partner. 'This depth of experience will be invaluable as we build this practice area into one of the finest and most effective in North Texas.' Mr. Guiltinan earned his law degree with honors from the Northwestern University School of Law and his undergraduate degree from Yale University. Last month, the firm announced the hiring of Richard Roper, a former U.S. Attorney for the Northern District, to lead its white-collar litigation practice. Through his tenure with the DOJ and 17 years in private practice, Mr. Roper has conducted more than 150 jury trials involving securities, healthcare fraud and public corruption. 'It's going to be an honor to work alongside Richard Roper,' says Mr. Guiltinan. 'I have enormous respect for him, and we share a vision for how this firm can add expertise and resources to provide our clients with high-quality representation that offers greater flexibility and fewer conflicts than larger firms. That's why I've made this move.' About Vartabedian Hester & Haynes Based in the Dallas-Fort Worth area, Vartabedian Hester & Haynes is a client-focused and results-oriented litigation boutique founded in early 2024. Learn more at

A mother's path from patient to women's health advocate
A mother's path from patient to women's health advocate

Business Journals

time01-08-2025

  • Business Journals

A mother's path from patient to women's health advocate

When Lauren Burrow walked into her 20-week prenatal ultrasound appointment in March 2022, she had no idea that a routine scan would change the course of her pregnancy — and her career — forever. Lauren, a mother of two at the time, was preparing to welcome her third child. Having already experienced two cesarean births; she was receiving prenatal care with Dr. Laura Pekman at Atrium Health Women's Care Charlotte OB-GYN. Things were progressing normally, until a routine anatomy scan raised some concerns. To take a closer look, Pekman referred Lauren to Dr. Jennifer Philips at Atrium Health Women's Care Maternal Fetal Medicine, who confirmed a serious diagnosis: placenta accreta spectrum (PAS), a serious condition where the placenta grows too deeply into the uterine wall. Lauren's ultrasound revealed both placenta previa — where the placenta covers the cervix —and placenta percreta, the most severe form of PAS, in which the placenta penetrates through the uterus. 'Placenta accreta spectrum disorders used to be very rare, about 1 in 2,000 pregnancies, but we're now seeing them in about 1 in 500,' Philips says. 'It can be life-threatening if not caught early, which is why continuity of care and timely referrals, like Lauren's, are so critical.' expand Navigating a high-risk pregnancy Lauren hadn't experienced any symptoms, so the diagnosis came as a surprise. When she learned she had PAS, she took precautions like pelvic rest and lifting restrictions to minimize complications. At seven months pregnant, a sudden bleeding episode sent Lauren to the hospital for a five-day stay, where a specialized team worked around the clock to ensure both mother and baby were safe. 'The hardest part wasn't the physical challenges. It was the emotional weight, the unknowns,' Lauren says. 'But the entire team was incredibly sensitive and reassuring. They helped me feel supported and prepared.' A team effort Knowing the risks, Lauren's obstetric team developed a specialized delivery plan. At 35 weeks, Lauren underwent a cesarean hysterectomy, the removal of the uterus at the time of cesarean delivery of the baby, the standard and safest treatment for severe PAS cases. A treatment that saved Lauren's life as she welcomed her new, beautiful baby daughter. Dr. Melissa Woolworth at Atrium Health Myers Park OB-GYN, director of complex delivery planning and placenta accreta center of excellence, performed Lauren's surgery, with Pekman assisting. This approach allowed her to remain in the care of her trusted physician while benefiting from the specialized expertise of Atrium Health's PAS team. 'Lauren's surgery was quite challenging due to the placenta percreta. But with our carefully curated protocol in place, we were able to complete the operation without complications,' Woolworth said. Philips adds, 'She didn't require a blood transfusion, which is quite rare for this condition. This goes to show that her surgical team did an exceptional job.' Lauren's recovery, however, wasn't easy. 'It was much tougher physically than my previous c-sections,' Lauren says. 'And emotionally, I was working through birth trauma and the loss of fertility. Even though a hysterectomy had been my plan, facing that reality was still hard.' As she healed, Lauren leaned on the support of her care team — not just for her physical recovery, but also for her emotional well-being. Their compassion, presence and attentiveness made a lasting impression during one of the most vulnerable times in her life. expand That care didn't just help Lauren safely welcome her daughter — it ignited something deeper that was connected to her emotional, as well as physical, journey. Though she had studied pre-med in college, Lauren pursued a career in law, working as a biomedical and pharmaceutical patent attorney. But during each of her pregnancies, especially her experience with PAS, she felt an undeniable pull back to medicine. 'I couldn't ignore it anymore,' Lauren says. 'I realized I was staying in a career that didn't fulfill me when I had a clear passion for women's health.' While still practicing law, Lauren became a certified birth doula and began taking courses to prepare for medical school. She officially left the legal field at the end of 2023. Now she supports women in childbirth and is preparing to apply to medical school. Philips, who has since developed a close friendship with Lauren, couldn't be prouder. Lauren remains active in the world of advocacy and has included both Woolworth and Philips in these events. 'It's been such a beautiful extension of our relationship to continue to work together to support maternal and reproductive health,' Woolworth says. 'It's incredibly rewarding to see how her experience shaped her purpose,' Philips says. 'Atrium Health's approach to maternal care is deeply rooted in collaboration, and Lauren's story is a testament to how that teamwork makes a difference — not just in outcomes, but in lives.' Today, Lauren is healthy and thriving, raising her three children — two sons and her youngest, affectionately known as her 'percreta princess,' who is now three years old. 'I'm just so grateful,' Lauren says. 'Not only did Atrium Health help save my life, they helped give me direction. The care I received was everything I needed, both as a patient and as a person.' Atrium Health is a nationally recognized leader in shaping health outcomes through innovative research, education and compassionate patient care. Based in Charlotte, North Carolina, Atrium Health is an integrated, nonprofit health system with more than 70,000 teammates serving patients at 40 hospitals and more than 1,400 care locations.

Cancer Risk in MMF-Treated Patients Differs by Indication
Cancer Risk in MMF-Treated Patients Differs by Indication

Medscape

time22-07-2025

  • Medscape

Cancer Risk in MMF-Treated Patients Differs by Indication

TOPLINE: Patients with dermatologic conditions showed a 74% lower risk for malignancy with mycophenolate mofetil (MMF) than transplant patients, a study found. METHODOLOGY: Researchers conducted a single-center retrospective chart of patients who had taken MMF for ≥ 5 years between 2012 and 2025 at Atrium Health Wake Forest Baptist Medical Center. The analysis included 126 patients (mean age, 64.2 years; 35.7% men) who received MMF for dermatologic conditions, 226 organ transplant recipients (mean age, 59.6 years; 61.5% men) who received MMF plus other immunosuppressive agents, and 296 patients (mean age, 64.1 year; 34.5% men) with dermatologic conditions who had no exposure to systemic immunosuppression. About two thirds of patients were White individuals and one fourth were Black individuals. Dermatologic patients received a mean daily MMF dose of 1390 mg over an average of 7.5 years, while transplant recipients received a lower mean daily dose of 807 mg for a mean duration of 9.9 years. Concomitant immunosuppressive therapy was administered to 40% of the patients with dermatologic conditions (MMF plus prednisone) and to 100% of transplant recipients (tacrolimus, prednisone, or cyclosporine). Researchers compared malignancy rates between the groups. TAKEAWAY: Overall, 9.5% of the dermatologic patients who received MMF developed malignancies compared with 36% of the transplant recipients (P < .0001); the risk for malignancy was 74% lower in dermatologic patients treated with MMF (95% CI, 0.1487-0.4518). No difference was found between dermatologic patients who received MMF vs those without exposure to systemic immunosuppression (8.4%). Cutaneous malignancies were significantly more common in transplant patients than in dermatologic patients who received MMF (26.5% vs 5.6%; P < .0001). The prevalence of urological/reproductive cancers was higher in transplant patients than dermatologic patients treated with MMF (9.3% vs 2.4%; P = .0143). IN PRACTICE: 'The use of MMF for dermatologic conditions does not appear to expose patients to the same malignancy risk as those treated with MMF and other chronic immunosuppressive treatments in the transplant setting and did not confer an elevated malignancy risk compared to dermatologic patients without systemic immunosuppression,' the authors of the study wrote. SOURCE: The study was led by Robin Yi, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, and was published online on July 17 in the Journal of the American Academy of Dermatology. LIMITATIONS: Limitations included the MMF dosing variability and small sample size. DISCLOSURES: The study did not receive any funding. One author reported receiving research, speaking and consulting support from numerous pharmaceutical companies including Eli Lilly, GlaxoSmithKline/Stiefel, AbbVie, and Janssen and disclosed being founder and part owner of Causa Research and holding stock in Sensal Health. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store